Objectives: To study clinical disease outcomes in both human and animal models to understand the pathogenicity of omicron compared to the delta variant.
Methods: In this cross-sectional observational study, clinical outcomes of adults who tested positive at 2 testing centres in Delhi National Capital Region between January 2022 and March 2022 (omicron-infected; N = 2998) were compared to a similar geographical cohort (delta-infected; N = 3292). In addition, disease course and outcomes were studied in SARS-CoV-2-infected golden Syrian hamsters and K-18 humanized ACE2 transgenic mice.
Results: Omicron variant infection was associated with a milder clinical course [83% (95% CI 61, 94) reduced risk of severity compared against delta] adjusting for vaccination, age, sex, prior infection and occupational risk. This correlated with lower disease index and vir comparing omicron with other variants in animal models.
Conclusions: Infections caused by the omicron variant were milder compared to those caused by the delta variant independent of previous immunity.
Keywords: COVID-19; Omicron; SARS-CoV-2; hACE2 transgenic mice; hamster.
© 2023. BioMed Central Ltd., part of Springer Nature.